Endocrinology, Vol 116, 1636-1644, Copyright © 1985 by Endocrine Society

ARTICLES

Enhancement of human growth hormone-stimulated mitogenesis of Nb2 node lymphoma cells by 12-O-tetradecanoyl-phorbol-13-acetate

A Gertler, A Walker and HG Friesen

The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) enhanced human (h) GH- and ovine PRL-stimulated mitogenesis of the Nb2-11C clone of rat lymphoma cells. Maximal enhancement of 25% in the proliferation rate was achieved with 20 nM TPA. The enhancing effect was found at all levels of hGH (0.031-2.0 ng/ml), but was more pronounced at lower hormone concentrations. TPA alone had no effect on cell proliferation, and its activity was absolutely dependent on the simultaneous presence of the lactogenic hormones. We have analyzed the changes that occurred in the distribution of cells in different phases of the cell cycle during the first 22 h after exposure to hGH and measured the proliferation rate through 3 days. We have found that the mitogenic effect of hGH resulted from 1) an increase in the rate of G0/G1----S transition, 2) a decrease in the lag period required for entry into the S phase, and 3) an increase in the number of cells entering this transition. TPA enhanced all three effects. Binding of [125I]hGH was not affected by prior exposure to TPA, suggesting that the effect of TPA is at a postreceptor level. Proliferation of an autonomous clone of Nb2 cells that does not require lactogenic hormones for growth was not stimulated by TPA, although these cells bound [3H]TPA to the same extent as the PRL-dependent Nb2-11C clone.

This article has been cited by other articles:

				C. Farmer and M.-F. Palin Exogenous prolactin stimulates mammary development and alters expression of prolactin-related genes in prepubertal gilts J Anim Sci, April 1, 2005; 83(4): 825 - 832. [Abstract] [Full Text] [PDF]

				C. K. L. Too, N. Vickaryous, R. T. M. Boudreau, and S. M. Sangster Identification and Nuclear Localization of a Novel Prolactin and Cytokine-Responsive Carboxypeptidase D Endocrinology, March 1, 2001; 142(3): 1357 - 1367. [Abstract] [Full Text] [PDF]

				D. Gullo, L. Sciacca, G. Parrinello, L. Tomaselli, and R. Vigneri Treatment of Hemangiopericytoma-Induced Hypoglycemia with Growth Hormone and Corticosteroids J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1758 - 1759. [Full Text]

				A. Herman, D. Helman, O. Livnah, and A. Gertler Ruminant Placental Lactogens Act as Antagonists to Homologous Growth Hormone Receptors and as Agonists to Human or Rabbit Growth Hormone Receptors J. Biol. Chem., March 19, 1999; 274(12): 7631 - 7639. [Abstract] [Full Text] [PDF]

				D. Helman, N. R. Staten, J. Byatt, J. Grosclaude, R. E. McKinnie, J. Djiane, and A. Gertler Site-Directed Mutagenesis of Recombinant Bovine Placental Lactogen at Lysine-73 Leads to Selective Attenuation of Its Somatogenic Activity Endocrinology, October 1, 1997; 138(10): 4069 - 4080. [Abstract] [Full Text] [PDF]

				D. Vashdi-Elberg, N. R. Staten, E. Sakal, R. E. McKinnie, J. Djiane, G. G. Krivi, and A. Gertler Selective Modification of Recombinant Bovine Placental Lactogen by Site-directed Mutagenesis at Its C Terminus J. Biol. Chem., March 8, 1996; 271(10): 5558 - 5564. [Abstract] [Full Text] [PDF]

				R. J. Duhé and W. L. Farrar Characterization of Active and Inactive Forms of the JAK2 Protein-tyrosine Kinase Produced via the Baculovirus Expression Vector System J. Biol. Chem., September 29, 1995; 270(39): 23084 - 23089. [Abstract] [Full Text] [PDF]